Intelligence / Healthtech / New Clinical Trials / Fisher and Paykel Healthcare
Clinicaltrial registered23 Oct 2026
Fisher and Paykel Healthcare
23 Oct 2026: Trial registered · Nasal High Flow Oxygen in Patients With Lower-Limb Ischaemia. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 23 Oct 2026
- Title
- Nasal High Flow Oxygen in Patients With Lower-Limb Ischaemia
- Conditions
- Lower Limb Ischaemia
- Phase
- Not applicable
- Study Type
- Interventional
- Status
- Not Yet Recruiting
- Reference
- NCT07891208
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Fisher and Paykel Healthcare
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for Fisher and Paykel Healthcare in our registers.
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.